All public logs
Jump to navigation
Jump to search
Combined display of all available logs of HemOnc.org - A Hematology Oncology Wiki. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).
(newest | oldest) View (newer 100 | older 100) (20 | 50 | 100 | 250 | 500)- 01:03, 2 May 2024 Jwarner talk contribs created page Category:Guideline pages (Created page with "Category:General reference pages")
- 21:54, 28 April 2024 Jwarner talk contribs created page Tovorafenib (Ojemda) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tovorafenib NCI Drug Dictionary]: An orally available inhibitor of wild-type...")
- 23:06, 22 April 2024 Jwarner talk contribs created page Nogapendekin alfa inbakicept (Anktiva) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nogapendekin-alfa NCI Drug Dictionary]: A fusion protein complex composed of...")
- 10:38, 14 April 2024 Jwarner talk contribs moved page Iptacopan (LNP-023) to Iptacopan (Fabhalta) (FDA approval)
- 18:05, 12 April 2024 Jwarner talk contribs created page CARv3-TEAM-E T-cells (Created page with "==Mechanism of action== anti-EGFR CAR T-cells ==Preliminary data== ===Glioblastoma=== #'''INCIPIENT:''' Choi BD, Gerstner ER, Frigault MJ, Leick MB, Mount CW, Balaj L, Ni...")
- 18:00, 12 April 2024 Jwarner talk contribs created page Category:SPEAR T-cells (Created page with "Category:Immune effector cells")
- 18:00, 12 April 2024 Jwarner talk contribs created page Category:Anti-MAGE-A4 SPEAR T-cells (Created page with "Category:SPEAR T-cells")
- 17:59, 12 April 2024 Jwarner talk contribs created page Category:Liposarcoma medications (investigational) (Created page with "Category:Liposarcoma medications")
- 17:59, 12 April 2024 Jwarner talk contribs created page Afamitresgene Autoleucel (ADP-A2M4) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afamitresgene-autoleucel NCI Drug Dictionary]: A preparation of autologous h...")
- 12:40, 10 April 2024 Jwarner talk contribs created page Hereditary hemorrhagic telangiectasia - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:25, 10 April 2024 Jwarner talk contribs created page Sickle cell anemia - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 11:21, 10 April 2024 Jwarner talk contribs created page Smoldering multiple myeloma - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 11:34, 9 April 2024 Jwarner talk contribs created page Category:FDA withdrawn in 2024 (Created page with "Category:Discontinued drugs")
- 17:43, 30 March 2024 Jwarner talk contribs created page Category:Myeloid neoplasms (Created page with "Category:Malignant hematologic neoplasm")
- 13:24, 4 March 2024 Jwarner talk contribs created page Category:Pyruvate kinase deficiency regimens (Created page with "Category:Classical hematology regimens")
- 13:23, 4 March 2024 Jwarner talk contribs created page Category:Pyruvate kinase deficiency medications (Created page with "Category:Classical hematology medications")
- 13:22, 4 March 2024 Jwarner talk contribs created page Pyruvate kinase deficiency (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 14:32, 28 February 2024 Jwarner talk contribs created page Category:Medications by manufacturing method (Created page with "Category:Drugs")
- 14:32, 28 February 2024 Jwarner talk contribs created page Category:Recombinant medications (Created page with "Category:Medications by manufacturing method")
- 14:27, 28 February 2024 Jwarner talk contribs created page Category:Profibrinolytics (Created page with "Category:Classical hematology medications")
- 14:06, 28 February 2024 Jwarner talk contribs created page Category:Hemoglobin S polymerization inhibitors (Created page with "Category:Classical hematology medications")
- 13:08, 24 February 2024 Jwarner talk contribs created page Category:Antineoplastic bispecific antibodies (Created page with "Category:Targeted therapeutic Category:Bispecific antibody medications")
- 13:05, 24 February 2024 Jwarner talk contribs created page Category:Hematologic bispecific antibodies (Created page with "Category:Bispecific antibody medications")
- 13:04, 24 February 2024 Jwarner talk contribs created page Category:Immunostimulatory bispecific antibodies (Created page with "Category:Bispecific antibody medications")
- 12:35, 2 February 2024 Jwarner talk contribs moved page Momelotinib (CYT-387) to Momelotinib (Ojjaara) (FDA approval)
- 12:35, 2 February 2024 Jwarner talk contribs created page Category:EMA approved in 2024 (Created page with "Category:EMA approved drugs")
- 21:49, 23 January 2024 Jwarner talk contribs moved page Ovarian cancer, BRCA-mutated to Ovarian cancer, HRD-positive (Renaming to make the page more generic for HRD rather than just BRCA)
- 02:02, 20 January 2024 Jwarner talk contribs created page Category:Bcl-2 translation inhibitors (Created page with "Category:Apoptosis promoters")
- 02:02, 20 January 2024 Jwarner talk contribs created page Oblimersen (Genasense) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oblimersen-sodium NCI Drug Dictionary]: The sodium salt of a phosphorothioat...")
- 15:41, 19 January 2024 Jwarner talk contribs created page Category:Ornithine decarboxylase inhibitors (Created page with "Category:Enzyme inhibitors")
- 15:41, 19 January 2024 Jwarner talk contribs created page Eflornithine (Iwilfin) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eflornithine-hydrochloride NCI Drug Dictionary]: A difluoromethylated ornith...")
- 01:26, 19 January 2024 Jwarner talk contribs created page Category:Complement pathway inhibitors (Created page with "Category:Hematology medications")
- 01:25, 19 January 2024 Jwarner talk contribs created page Category:Complement factor D inhibitors (Created page with "Category:Complement pathway inhibitors")
- 01:24, 19 January 2024 Jwarner talk contribs created page Danicopan (ALXN-2040) (Created page with "==Mechanism of action== Complement factor D inhibitor ==Preliminary data== ===Paroxysmal nocturnal hemoglobinuria (PNH)=== #'''ALPHA:'...")
- 18:06, 18 January 2024 Jwarner talk contribs created page Category:Anti-DLL3-CD3 bispecific antibodies (Created page with "Category:Bispecific antibody medications")
- 18:05, 18 January 2024 Jwarner talk contribs created page Tarlatamab (AMG-757) (Created page with "==Mechanism of action== From the NCI Drug Dictionary: A bispecific T-cell engager (BiTE) antibody composed of two single-chain variable fragments (scFv), one directed against...")
- 12:18, 12 January 2024 Jwarner talk contribs created page Category:Cutaneous T-cell lymphoma medications (investigational) (Created page with "Category:Cutaneous T-cell lymphoma medications")
- 11:42, 6 January 2024 Jwarner talk contribs created page Category:Hepatic veno-occlusive disease medications (Created page with "Category:Supportive medications")
- 11:36, 6 January 2024 Jwarner talk contribs created page Category:Acute lymphoblastic leukemia medications (Created page with "Category:Leukemia medications")
- 11:36, 6 January 2024 Jwarner talk contribs created page Category:Acute lymphoblastic leukemia, infant medications (Created page with "Category:Acute lymphoblastic leukemia medications")
- 02:30, 2 January 2024 Jwarner talk contribs created page Category:FDA approved in 2024 (Created page with "Category:FDA approved drugs")
- 03:33, 30 December 2023 Jwarner talk contribs created page Hypereosinophilic syndrome - null regimens (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. These references provide further insight into the historical development o...")
- 13:59, 20 December 2023 Jwarner talk contribs created page Category:FAK inhibitors (Created page with "Category:Tyrosine kinase inhibitors")
- 13:58, 20 December 2023 Jwarner talk contribs created page Repotrectinib (Augtyro) (Created page with "==General information== Class/mechanism from the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/repotrectinib NCI Drug Dictionary]: An orally available inhi...")
- 00:18, 17 December 2023 Jwarner talk contribs created page Glioblastoma - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 01:26, 2 December 2023 Jwarner talk contribs created page Autologous stem cells (Created page with "==General information== Class/mechanism: Hematopoietic stem/progenitor cells from the individual who is receiving the infusion <br>Route: IV <br>Extravasation: No information...")
- 23:46, 27 November 2023 Jwarner talk contribs moved page Nirogacestat (PF-03084014) to Nirogacestat (Ogsiveo) (FDA approval)
- 17:31, 26 November 2023 Jwarner talk contribs moved page Category:Local therapies to Category:Locally delivered therapies
- 15:13, 26 November 2023 Jwarner talk contribs created page Category:Cellular therapy regimens (Created page with "Category:Regimen index")
- 15:10, 26 November 2023 Jwarner talk contribs moved page Chimeric antigen receptor T cells (CAR-T) to Cellular therapy conditioning regimens
- 15:09, 26 November 2023 Jwarner talk contribs moved page Stem cell mobilization to Stem cell mobilization regimens
- 15:07, 26 November 2023 Jwarner talk contribs moved page Autologous HSCT to Autologous HSCT conditioning regimens over redirect
- 15:07, 26 November 2023 Jwarner talk contribs deleted redirect Autologous HSCT conditioning regimens by overwriting (Deleted to make way for move from "Autologous HSCT")
- 15:05, 26 November 2023 Jwarner talk contribs moved page Allogeneic HSCT to Allogeneic HSCT conditioning regimens over redirect
- 15:05, 26 November 2023 Jwarner talk contribs deleted redirect Allogeneic HSCT conditioning regimens by overwriting (Deleted to make way for move from "Allogeneic HSCT")
- 13:55, 26 November 2023 Jwarner talk contribs moved page Niraparib and Abiraterone (Akeega) to Niraparib and abiraterone (Akeega)
- 03:09, 26 November 2023 Jwarner talk contribs moved page Mycostatin (Nystatin) to Nystatin (Mycostatin) (error in brand naming)
- 18:15, 19 November 2023 Jwarner talk contribs created page Category:PARP2 inhibitors (Created page with "Category:PARP inhibitors")
- 18:15, 19 November 2023 Jwarner talk contribs created page Category:PARP1 inhibitors (Created page with "Category:PARP inhibitors")
- 18:05, 19 November 2023 Jwarner talk contribs created page Category:TYK2 inhibitors (Created page with "A member of the Janus kinase family of tyrosine kinases. Category:JAK inhibitors")
- 14:14, 18 November 2023 Jwarner talk contribs moved page Toripalimab (Loqtorz) to Toripalimab (Loqtorzi) (Brand name not spelled right)
- 15:10, 17 November 2023 Jwarner talk contribs created page Category:Aromatase inhibitors, third generation (Created page with "Category:Aromatase inhibitors")
- 15:09, 17 November 2023 Jwarner talk contribs created page Category:Aromatase inhibitors, second generation (Created page with "Category:Aromatase inhibitors")
- 15:08, 17 November 2023 Jwarner talk contribs created page Category:Aromatase inhibitors, first generation (Created page with "Category:Aromatase inhibitors")
- 15:03, 17 November 2023 Jwarner talk contribs created page Category:PMDA approved in 1995 (Created page with "Category:PMDA approved drugs")
- 14:26, 17 November 2023 Jwarner talk contribs moved page Anlotinib (AL-3818) to Anlotinib (Fukewei) (brand name)
- 12:32, 17 November 2023 Jwarner talk contribs moved page Capivasertib (AZD-5363) to Capivasertib (Truqap) (FDA approval)
- 11:50, 17 November 2023 Jwarner talk contribs created page Thyroid cancer, medullary - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 20:16, 15 November 2023 Jwarner talk contribs created page NCCN guidelines (Created page with "This page will be a gathering place for the National Comprehensive Cancer Network (NCCN) guidelines that do not clearly fit under a disease-specific page. '''Given the rapid...")
- 00:44, 13 November 2023 Jwarner talk contribs created page Upper tract urothelial carcinoma - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 20:12, 7 November 2023 Jwarner talk contribs created page Category:EMA approved in 1977 (Created page with "Category:EMA approved drugs")
- 17:12, 7 November 2023 Jwarner talk contribs moved page Bacillus Calmette-Guérin (BCG) to BCG vaccine (INN)
- 01:28, 7 November 2023 Jwarner talk contribs created page CRC (Redirected page to Colorectal cancer) Tag: New redirect
- 01:00, 7 November 2023 Jwarner talk contribs created page Category:Warm autoimmune hemolytic anemia medications (Created page with "Category:Classical hematology medications")
- 00:59, 7 November 2023 Jwarner talk contribs created page Category:EMA approved in 1955 (Created page with "Category:EMA approved drugs")
- 00:55, 7 November 2023 Jwarner talk contribs created page Category:Colorectal cancer medications (historic) (Created page with "Category:Colorectal cancer medications")
- 23:16, 6 November 2023 Jwarner talk contribs created page Category:Acquired hemophilia A medications (Created page with "Category:Acquired coagulopathy medications")
- 20:57, 6 November 2023 Jwarner talk contribs created page Mitomycin pyelocalyceal (Jelmyto) (Created page with "==Mechanism of action== Antibiotic oncologic isolated from Streptomyces caespitosus; inhibits DNA synthesis and induces crosslinking. Formulated for pyelocalyceal infusion. =...")
- 20:28, 6 November 2023 Jwarner talk contribs created page Lasofoxifene (Fablyn) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lasofoxifene NCI Drug Dictionary]: A non-steroidal, naphthalene-derived, thi...")
- 20:08, 6 November 2023 Jwarner talk contribs created page Fadrozole (Afema) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fadrozole-hydrochloride NCI Data Dictionary]: The hydrochloride salt of the...")
- 19:33, 6 November 2023 Jwarner talk contribs created page Dinutuximab beta (Qarziba) (Created page with "==Mechanism of action== Anti-GD2 antibody ==Diseases for which it is used== *Neuroblastoma ==History of changes in EMA indication== *2017-05-08: Initial authorisation as...")
- 19:04, 6 November 2023 Jwarner talk contribs created page Chlorozotocin (DCNU) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorozotocin NCI Drug Dictionary]: A glucose-linked chloroethylnitrosourea...")
- 18:59, 6 November 2023 Jwarner talk contribs created page Trastuzumab-zerc (Zercepac) (Created page with "'''Note: this is a trastuzumab biosimilar.''' ==Also known as== *'''Brand name:''' Zercepac Category:Drugs Category:Intravenous medications Category:Neutral C...")
- 18:59, 6 November 2023 Jwarner talk contribs created page Trastuzumab-herw (Herwenda) (Created page with "'''Note: this is a trastuzumab biosimilar.''' ==Also known as== *'''Brand name:''' Herwenda Category:Drugs Category:Intravenous medications Category:Neutral C...")
- 18:58, 6 November 2023 Jwarner talk contribs created page Rituximab-rixi (Riximyo) (Created page with "'''Note: this is a rituximab biosimilar.''' ==Also known as== *'''Brand name:''' Riximyo Category:Drugs Category:Intravenous medications Category:Neutral Cate...")
- 18:58, 6 November 2023 Jwarner talk contribs created page Rituximab-rixa (Rixathon) (Created page with "'''Note: this is a rituximab biosimilar.''' ==Also known as== *'''Brand name:''' Rixathon Category:Drugs Category:Intravenous medications Category:Neutral Cat...")
- 18:58, 6 November 2023 Jwarner talk contribs created page Rituximab-rite (Ritemvia) (Created page with "'''Note: this is a rituximab biosimilar.''' ==Also known as== *'''Brand name:''' Ritemvia Category:Drugs Category:Intravenous medications Category:Neutral Cat...")
- 18:58, 6 November 2023 Jwarner talk contribs created page Rituximab-blit (Blitzima) (Created page with "'''Note: this is a rituximab biosimilar.''' ==Also known as== *'''Brand name:''' Blitzima Category:Drugs Category:Intravenous medications Category:Neutral Cat...")
- 18:57, 6 November 2023 Jwarner talk contribs created page Bevacizumab-onbe (Onbevzi) (Created page with "'''Note: this is a bevacizumab biosimilar.''' ==Also known as== *'''Brand name:''' Onbevzi Category:Drugs Category:Intravenous medications Category:Neutral Ca...")
- 18:56, 6 November 2023 Jwarner talk contribs created page Bevacizumab-equi (Equidacent) (Created page with "'''Note: this is a bevacizumab biosimilar.''' ==Also known as== *'''Brand name:''' Equidacent Category:Drugs Category:Intravenous medications Category:Neutral [...")
- 18:56, 6 November 2023 Jwarner talk contribs created page Bevacizumab-aybi (Aybintio) (Created page with "'''Note: this is a bevacizumab biosimilar.'' ==Also known as== *'''Brand name:''' Aybintio Category:Drugs Category:Intravenous medications Category:Neutral Ca...")
- 13:59, 6 November 2023 Jwarner talk contribs created page Anlotinib (AL-3818) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/catequentinib-hydrochloride NCI Drug Dictionary]: The hydrochloride salt for...")
- 12:15, 6 November 2023 Jwarner talk contribs created page Cutaneous squamous cell carcinoma - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 13:04, 5 November 2023 Jwarner talk contribs created page Systemic mastocytosis - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:54, 5 November 2023 Jwarner talk contribs created page Polycythemia vera - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:12, 5 November 2023 Jwarner talk contribs created page Meningioma - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:07, 5 November 2023 Jwarner talk contribs created page B-cell lymphoma of mucosa-associated lymphoid tissue - historical (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:00, 5 November 2023 Jwarner talk contribs created page B-cell lymphoma of mucosa-associated lymphoid tissue - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 11:36, 5 November 2023 Jwarner talk contribs created page JMML (Redirected page to Juvenile myelomonocytic leukemia) Tag: New redirect
- 00:14, 4 November 2023 Jwarner talk contribs moved page Fruquintinib (HMPL-013) to Fruquintinib (Elunate) (brand name)